Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $125B | +$4.71B | 156 | 4.27% | Increased |
|
| 2 |
BlackRock
New York
| $114B | +$4.64B | 169 | 4.37% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $73.1B | +$2.23B | 125 | 5% | Increased |
|
| 4 |
Wellington Management Group
Boston,
Massachusetts
| $32.3B | -$1.2B | 59 | 6.77% | Reduced |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $30B | +$1.87B | 94 | 3.31% | Increased |
|
| 6 |
Capital Research Global Investors
Los Angeles,
California
| $23.3B | -$195M | 13 | 6.98% | Reduced |
|
| 7 |
Geode Capital Management
Boston,
Massachusetts
| $23.2B | +$1.19B | 167 | 4.84% | Increased |
|
| 8 |
Bank of America
Charlotte,
North Carolina
| $21B | +$495M | 156 | 3% | Increased |
|
| 9 |
Capital World Investors
Los Angeles,
California
| $20.3B | -$2.89B | 18 | 4.53% | Reduced |
|
| 10 |
Northern Trust
Chicago,
Illinois
| $19.8B | +$18.4M | 150 | 4.43% | Increased |
|
| 11 |
T. Rowe Price Associates
Baltimore,
Maryland
| $19.2B | +$1.31B | 69 | 2.49% | Increased |
|
| 12 |
Bank of New York Mellon
New York
| $18B | +$594M | 127 | 4.65% | Increased |
|
| 13 |
JP Morgan Chase
New York
| $17.1B | +$1.05B | 131 | 3.19% | Increased |
|
| 14 |
Norges Bank
Oslo,
Norway
| $16B | +$566M | 51 | 4.48% | Increased |
|
| 15 |
Capital International Investors
Los Angeles,
California
| $15.5B | -$500M | 21 | 5.26% | Reduced |
|
| 16 |
Primecap Management
Pasadena,
California
| $14.4B | -$99.6M | 17 | 10.43% | Reduced |
|
| 17 |
Morgan Stanley
New York
| $12.5B | +$1.06B | 187 | 2.9% | Increased |
|
| 18 |
Goldman Sachs
New York
| $11.9B | +$1.44B | 115 | 3.04% | Increased |
|
| 19 |
Wells Fargo
San Francisco,
California
| $11.9B | -$41.5M | 149 | 3.19% | Reduced |
|
| 20 |
Nuveen
Charlotte,
North Carolina
| $11.7B | +$906M | 98 | 4.43% | Increased |
|
| 21 |
Renaissance Technologies
New York
| $11.3B | +$2.26B | 124 | 8.72% | Increased |
|
| 22 |
BBA
Baker Bros. Advisors
New York
| $11.3B | +$240M | 34 | 59.91% | Increased |
|
| 23 |
Dodge & Cox
San Francisco,
California
| $11.3B | -$764M | 11 | 8.62% | Reduced |
|
| 24 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
| $10.1B | -$720M | 7 | 12.65% | Reduced |
|
| 25 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $9.79B | +$525M | 148 | 6.38% | Increased |
|